N2OFF shareholders approve acquisition of MitoCareX drug discovery unit
Go back to N2OFF shareholders approve acquisition of MitoCareX drug discovery unit| (NASDAQ: NITO) | Delayed: 1.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.22 | 52 Week High | $ | |||
| Open | $1.22 | 52 Week Low | $ | |||
| Day High | $1.22 | P/E | N/A | |||
| Day Low | $1.22 | EPS | $ | |||
| Volume | 537 | |||||
| (NASDAQ: SPRC) | Delayed: 4.95 -0.15 (2.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.10 | 52 Week High | $ | |||
| Open | $5.11 | 52 Week Low | $ | |||
| Day High | $5.11 | P/E | N/A | |||
| Day Low | $4.95 | EPS | $ | |||
| Volume | 16,974 | |||||

